Literature DB >> 25384710

The Etiology of Juvenile Idiopathic Arthritis.

Donato Rigante1, Annalisa Bosco2, Susanna Esposito3.   

Abstract

Over the years, the commonly used term to describe juvenile idiopathic arthritis (JIA) has changed. By definition, JIA includes all types of arthritis with no apparent cause, lasting more than 6 weeks, in patients aged less than 16 years at onset. JIA pathogenesis is still poorly understood: the interaction between environmental factors and multiple genes has been proposed as the most relevant working mechanism to the development of JIA. The concept that various microbes that colonize or infect not only the mucosal surfaces, like the oral cavity, but also the airways and gut might trigger autoimmune processes, resulting in chronic arthritides, and JIA was first drafted at the outset of last century. JIA development might be initiated and sustained by the exposure to environmental factors, including infectious agents which affect people at a young age, depending on the underlying genetic predisposition to synovial inflammation. Many data from patients with JIA suggest a scenario in which different external antigens incite multiple antigen-specific pathways, cytotoxic T cell responses, activation of classical complement cascade, and production of proinflammatory cytokines. In this review, emphasis is paid not only to the potential role of parvovirus B19 and Epstein-Barr virus in primis but also to the general involvement of different bacteria as Salmonella spp., Shigella spp., Campylobacter spp., Mycoplasma pneumoniae, Chlamydophila pneumoniae, Bartonella henselae, and Streptococcus pyogenes for the development of immune-mediated arthritides during childhood. No unequivocal evidence favoring or refuting these associations has been clearly proved, and today, the strict definition of JIA etiology remains unknown. The infection can represent a random event in a susceptible individual, or it can be a necessary factor in JIA development, always in combination with a peculiar genetic background. Further studies are needed in order to address the unsolved questions concerning this issue.

Entities:  

Keywords:  Child; Infection; Juvenile idiopathic arthritis

Mesh:

Year:  2015        PMID: 25384710     DOI: 10.1007/s12016-014-8460-9

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  67 in total

1.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

Review 2.  Immunosenescence and juvenile idiopathic arthritis.

Authors:  Christina Mayerl; Martina Prelog
Journal:  Autoimmun Rev       Date:  2010-02-19       Impact factor: 9.754

Review 3.  Genetic analysis of juvenile rheumatoid arthritis: approaches to complex traits.

Authors:  Sampath Prahalad
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2006-03

Review 4.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

5.  Association of Chlamydia pneumoniae with chronic juvenile arthritis.

Authors:  D Taylor-Robinson; B Thomas; M Rooney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

6.  Remission of juvenile idiopathic arthritis with primary Epstein-Barr virus infection.

Authors:  Jun-Ichi Kawada; Yoshinori Ito; Yuka Torii; Hiroshi Kimura; Naomi Iwata
Journal:  Rheumatology (Oxford)       Date:  2012-10-30       Impact factor: 7.580

7.  The role of microbial byproducts in protection against immunological disorders and the hygiene hypothesis.

Authors:  Soo Mun Ngoi; Francisco A Sylvester; Anthony T Vella
Journal:  Discov Med       Date:  2011-11       Impact factor: 2.970

8.  Bartonella infection associated with systemic juvenile rheumatoid arthritis.

Authors:  M Tsukahara; H Tsuneoka; H Tateishi; K Fujita; M Uchida
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

9.  Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.

Authors:  Philipp Von Landenberg; Hartwig W Lehmann; Antje Knöll; Simone Dorsch; Susanne Modrow
Journal:  Arthritis Rheum       Date:  2003-07

10.  Juvenile rheumatoid arthritis in children with Ebstein Barr virus infection.

Authors:  Y Aghighi; Modarres Gilani Sh; M Razavi; A Zamani; K Daneshjoo
Journal:  Pak J Biol Sci       Date:  2007-10-15
View more
  11 in total

1.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

Review 2.  Juvenile idiopathic arthritis: what is the utility of ultrasound?

Authors:  Hershernpal A S Basra; Paul D Humphries
Journal:  Br J Radiol       Date:  2017-04-06       Impact factor: 3.039

3.  A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.

Authors:  Daniel J Lovell; Jason A Dare; Megan Francis-Sedlak; Julie Ball; Brian D LaMoreaux; Emily Von Scheven; Adam Reinhardt; Rita Jerath; Oral Alpan; Ramesh Gupta; Donald Goldsmith; Andrew Zeft; Henry Naddaf; Beth Gottlieb; Lawrence Jung; Robert J Holt
Journal:  Pediatr Rheumatol Online J       Date:  2018-06-26       Impact factor: 3.054

4.  Correlation of ultrasonography synovitis with disease activity and clinical response to etanercept treatment in juvenile idiopathic arthritis patients.

Authors:  Li Zhou; Xiaojie Gu
Journal:  Braz J Med Biol Res       Date:  2019-11-25       Impact factor: 2.590

Review 5.  Review of environmental factors and juvenile idiopathic arthritis.

Authors:  Daniel B Horton; Susan Shenoi
Journal:  Open Access Rheumatol       Date:  2019-11-06

Review 6.  Alterations of Extracellular Matrix Components in the Course of Juvenile Idiopathic Arthritis.

Authors:  Magdalena Wojdas; Klaudia Dąbkowska; Katarzyna Winsz-Szczotka
Journal:  Metabolites       Date:  2021-02-25

7.  Mycoplasma pneumoniae Seroprevalence and Total IgE Levels in Patients with Juvenile Idiopathic Arthritis.

Authors:  Dimitri Poddighe; Diyora Abdukhakimova; Kuanysh Dossybayeva; Zaure Mukusheva; Maykesh Assylbekova; Marzhan Rakhimzhanova; Aigul Ibrayeva; Gaukhar Mukash; Yernas Tuleutayev
Journal:  J Immunol Res       Date:  2021-10-06       Impact factor: 4.818

Review 8.  B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

Authors:  Rita A Moura; João Eurico Fonseca
Journal:  Front Med (Lausanne)       Date:  2022-04-04

Review 9.  The human microbiome and juvenile idiopathic arthritis.

Authors:  Anouk Verwoerd; Nienke M Ter Haar; Sytze de Roock; Sebastiaan J Vastert; Debby Bogaert
Journal:  Pediatr Rheumatol Online J       Date:  2016-09-20       Impact factor: 3.054

10.  Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study.

Authors:  Ewa Gruszewska; Magdalena Sienkiewicz; Paweł Abramowicz; Jerzy Konstantynowicz; Monika Gudowska-Sawczuk; Lech Chrostek; Bogdan Cylwik
Journal:  Rheumatol Int       Date:  2018-05-14       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.